文献速递血栓与止血

伴与不伴血流动力学不稳定的急性肺栓塞(2003-2022年):一项瑞士全国性流行病学研究

Acute pulmonary embolism with and without hemodynamic instability (2003-2022): a Swiss nationwide epidemiologic study.
PubMed 文献 · J Thromb Haemost · 2025-01-10

该研究基于2003至2022年瑞士全国患者层面数据(N=180 600)及死亡登记,分析急性肺栓塞的年龄标化发病率、死亡率、院内病死率和住院时长,并按性别及高危肺栓塞特征分层。结果显示发病率上升、死亡率与院内病死率下降、住院时长缩短,高危特征患者除住院时长外趋势相似。

要点

  • 急性肺栓塞年龄标化发病率从2003年每1000人0.87升至2022年1.19。
  • 死亡率从2003年每10万人18.7降至2022年13,院内病死率从9.8%降至2019年7.9%。
  • 住院时长中位数从2003年11天降至2022年8天,高危特征患者趋势相似。

核心结论

  • 瑞士急性肺栓塞发病率在过去20年上升,但院内病死率和死亡率下降,住院时长逐渐缩短。
  • 高危特征患者除住院时长缩短外,其他趋势与总体相似。

研究设计与样本

  • 全国性患者层面数据研究,纳入2003至2022年瑞士所有15岁及以上因肺栓塞住院的患者,共N=180 600例。
  • 同时分析同期瑞士死亡登记数据。
  • 估计疾病特异性年龄标化发病率、死亡率、院内病死率、比例死亡率和住院时长,并按性别及高危肺栓塞特征分层。

主要发现

  • 肺栓塞相关发病率从2003年每1000人口0.87(95%CI:0.82,0.92)上升至2022年1.19(95%CI:1.15,1.24)。
  • 死亡率从2003年每10万人口18.7(95%CI:16.8,20.6)下降至2022年13(95%CI:11.7,14.2)。
  • 院内病死率从2003年每100例住院肺栓塞患者9.8例死亡(95%CI:9.1,10.5)降至2019年7.9例(95%CI:7.4,8.5),COVID-19大流行期间随后上升。
  • 住院时长从2003年11天(Q1-Q3:7-18)降至2022年8天(Q1-Q3:4-16)。
  • 趋势无重大性别差异;高危特征患者除住院时长缩短外,其他趋势相似。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Data on the epidemiologic burden of acute pulmonary embolism (PE) in Switzerland are unavailable. Knowledge gaps remain on trends in PE-related comorbidities, PE severity, and length of in-hospital stay (LOS) at a nationwide level. OBJECTIVES: To study the epidemiology of acute PE with a focus on overall trends, sex-stratified trends, and trends in patients with (vs without) hemodynamic instability. METHODS: We used nationwide, patient-level data including all patients aged 15 years or older hospitalized for PE in Switzerland from 2003 to 2022, amounting to N = 180 600. Additionally, we analyzed the Swiss Death Registry for the same period. We estimated the disease-specific age-standardized incidence rates, mortality rates, in-hospital case fatality rates, proportional mortality rates, and LOS. Analyses were stratified by sex and the presence of features of high-risk PE. RESULTS: During the study period, the PE-related incidence rate increased from 0.87 (95% CI: 0.82, 0.92) per 1000 population in 2003 to 1.19 (95% CI: 1.15, 1.24) in 2022. In contrast, a decreasing trend was found for mortality rates (18.7 [95% CI: 16.8, 20.6] per 100 000 population in 2003, 13 [95% CI: 11.7,14.2] in 2022), in-hospital case fatality rate (9.8 [95% CI: 9.1, 10.5] deaths per 100 hospitalized PE patients in 2003, 7.9 [95% CI: 7.4, 8.5] in 2019, subsequent increase during COVID-19 pandemic), and LOS (11 [Q1-Q3: 7-18] days in 2003, 8 [Q1-Q3: 4-16] in 2022). No major sex differences in trends were present. Except for LOS reduction, patients with high-risk features presented with similar trends. CONCLUSION: The incidence of acute PE in Switzerland increased over the last 20 years. Despite increasing trends in the median age at PE diagnosis, in-hospital case fatality and mortality rates decreased, particularly among patients with high-risk features, and the LOS progressively declined.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Wolf S, Valerio L, Fumagalli RM, et al. Acute pulmonary embolism with and without hemodynamic instability (2003-2022): a Swiss nationwide epidemiologic study. J Thromb Haemost. 2025. PMID: 39800256. doi:10.1016/j.jtha.2024.12.040

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。